HCW Biologics is trading 5.98% down at $3.23 after failing to extend its recent rally.

  • The stock declined from $3.60 on August 4 to $3.43 on August 5 and $3.23 currently on August 6.
  • No new company-specific announcement explaining the decline was identified.
  • The earlier $1.6 million insider-backed private placement remains relevant background but does not directly explain today’s drop.